1. Extracellular vesicles and ctDNA in lung cancer: biomarker sources and therapeutic applications

   • Chengliang Huang
   • Sitong Liu
   • Hong Fan

   Review Article 08 June 2018 Pages: 171 - 183

   

2. The natural agent 4-vinylphenol targets metastasis and stemness features in breast cancer stem-like cells

   • Hoi-Wing Leung
   • Chun-Hay Ko
   • Clara Bik-San Lau

   Original Article 18 May 2018 Pages: 185 - 197

   

3. Overexpression of ABCB4 contributes to acquired doxorubicin resistance in breast cancer cells in vitro

   • Jia-Feng Huang
   • Chun-Jie Wen
   • Hong-Hao Zhou

   Original Article 18 May 2018 Pages: 199 - 210

   

4. Pharmacodynamic study using FLT PET/CT in advanced solid malignancies treated with a sequential combination of X-82 and docetaxel

   • Matthew Scarpelli
   • Murtuza Rampurwala
   • Justine Yang Bruce

   Original Article 25 May 2018 Pages: 211 - 219

   

5. Relationship of peak serum methotrexate concentration to prognosis and drug tolerance in non-metastatic extremity osteosarcomas

   • Bo Wang
   • Hao Yao
   • Jingnan Shen

   Original Article 28 May 2018 Pages: 221 - 227

   

6. Clinical pharmacokinetics and safety profile of single agent arsenic trioxide by continuous slow-rate infusion in patients with newly diagnosed acute promyelocytic leukemia

   • Chunlu Gao
   • Shuang Hu
   • Jin Zhou

   Original Article 29 May 2018 Pages: 229 - 236

   

7. The association of polymorphisms in folate-metabolizing genes with response to adjuvant chemotherapy of colorectal cancer

   • Al-Motassem Yousef
   • Mohammed Zawiah
   • Hanguin Al-Ramadhani

   Original Article 29 May 2018 Pages: 237 - 243

   

8. Gemcitabine plus nab-paclitaxel vs. FOLFIRINOX for patients with advanced pancreatic cancer

   • Junko Tahara
   • Kyoko Shimizu
   • Katsutoshi Tokushige

   Original Article 30 May 2018 Pages: 245 - 250

   

9. Targeting ALK in pediatric RMS does not induce antitumor activity in vivo

   • Monika Wierdl
   • Lyudmila Tsurkan
   • Philip M. Potter

   Original Article 31 May 2018 Pages: 251 - 263

   

10. Pulmonary administration of curcumin inhibits B16F10 melanoma lung metastasis and invasion in mice

    • Ken Shimada
    • Kentaro Ushijima
    • Akio Fujimura

    Original Article 04 June 2018 Pages: 265 - 273

    

11. Efficacy of capecitabine in patients with locally advanced or metastatic breast cancer with or without prior treatment with fluoropyrimidine: a retrospective study

    • Sakura Iizumi
    • Akihiko Shimomura
    • Kenji Tamura

    Original Article Open access 05 June 2018 Pages: 275 - 283

    

12. Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer

    • Jordi Rodon
    • Alejandro Pérez-Fidalgo
    • Jose Baselga

    Original Article 07 June 2018 Pages: 285 - 298

    

13. The pH-altering agent omeprazole affects rate but not the extent of ibrutinib exposure

    • Jan de Jong
    • Nahor Haddish-Berhane
    • Daniele Ouellet

    Original Article 07 June 2018 Pages: 299 - 308

    

14. A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors

    • Amikar Sehdev
    • Theodore Karrison
    • Manish R. Sharma

    Original Article 09 June 2018 Pages: 309 - 317

    

15. Over-adherence to capecitabine: a potential safety issue in breast and colorectal cancer patients

    • Olivia Le Saux
    • Aurélie Bourmaud
    • Véronique Trillet-Lenoir

    Original Article 15 June 2018 Pages: 319 - 327

    

16. Pharmacokinetic and pharmacodynamic bioequivalence study of a pegfilgrastim biosimilar INTP5 in healthy subjects

    • Inderjeet Singh
    • Akash Patel
    • Vinu Jose

    Original Article 15 June 2018 Pages: 329 - 337

    

17. Phase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumors

    • Colin D. Weekes
    • Lee S. Rosen
    • Alberto Bessudo

    Original Article 15 June 2018 Pages: 339 - 351

    

18. Phase II study of pazopanib in combination with paclitaxel in patients with metastatic melanoma

    • John P. Fruehauf
    • Monica El-Masry
    • James G. Jakowatz

    Clinical Trial Report Open access 25 June 2018 Pages: 353 - 360

    

19. Therapeutic drug monitoring and dose adaptation of cisplatin in a newborn with hepatoblastoma: a case report

    • Fabienne Thomas
    • Gareth J. Veal
    • Christophe Piguet

    Short Communication 19 June 2018 Pages: 361 - 365

    

20. Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma

    • Jie Weng
    • Mengyun Tu
    • Zhiyi Wang

    Letter to the Editor 15 March 2018 Pages: 367 - 367

21. Reply to: Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma

    • Kyoichi Kaira

    Letter to the Editor 25 June 2018 Pages: 369 - 369